Home › Entities › clinical_trial › Synergetic B-cell Immunomodulation in SLE - 2nd Study.

Synergetic B-cell Immunomodulation in SLE - 2nd Study.

clinical trial
MedicalStudy clinical_trial Q62034355
Press Enter · cited answer in seconds

Synergetic B-cell Immunomodulation in SLE - 2nd Study.

Summary

Synergetic B-cell Immunomodulation in SLE - 2nd Study. is a clinical trial[1].

Key Facts

  • Synergetic B-cell Immunomodulation in SLE - 2nd Study. is in the country of Netherlands[2].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s instance of is recorded as clinical trial[3].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s start time is recorded as +2018-10-01T00:00:00Z[4].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s end time is recorded as +2020-10-31T00:00:00Z[5].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s sponsor is recorded as Leiden University Medical Center[6].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s main subject is recorded as kidney failure[7].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s number of participants is recorded as {'unit': '1', 'amount': '+30'}[8].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s title is recorded as A Randomized Trial to Investigate the Reset of Humoral Autoimmunity by Combining Belimumab With Rituximab in Severe Systemic Lupus Erythematosus[9].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s short name is recorded as SynBioSe-2[10].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s ClinicalTrials.gov ID is recorded as NCT03747159[12].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s research intervention is recorded as mycophenolic acid[13].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s research intervention is recorded as belimumab[14].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s research intervention is recorded as methylprednisolone[15].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s research intervention is recorded as rituximab[16].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s clinical trial phase is recorded as phase II clinical trial[17].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s research subject recruitment status is recorded as recruiting[18].
  • Synergetic B-cell Immunomodulation in SLE - 2nd Study.'s study type is recorded as interventional study[19].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Synergetic B-cell Immunomodulation in SLE - 2nd Study.. Retrieved May 3, 2026, from https://4ort.xyz/entity/synergetic-b-cell-immunomodulation-in-sle-2nd-study-
MLA “Synergetic B-cell Immunomodulation in SLE - 2nd Study..” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/synergetic-b-cell-immunomodulation-in-sle-2nd-study-.
BibTeX @misc{4ortxyz_synergetic-b-cell-immunomodulation-in-sle-2nd-study-_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Synergetic B-cell Immunomodulation in SLE - 2nd Study.}}, year = {2026}, url = {https://4ort.xyz/entity/synergetic-b-cell-immunomodulation-in-sle-2nd-study-}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Synergetic B-cell Immunomodulation in SLE - 2nd Study. — https://4ort.xyz/entity/synergetic-b-cell-immunomodulation-in-sle-2nd-study- (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/synergetic-b-cell-immunomodulation-in-sle-2nd-study- · Last refreshed: